AbbVie (ABBV) Finished Goods (2012 - 2016)
AbbVie (ABBV) posted quarterly Finished Goods of $556.0 million for Q2 2016, up 16.32% year-over-year from $478.0 million in Q3 2015, and up 0.72% quarter-over-quarter from $552.0 million in Q1 2016.
AbbVie (ABBV) Finished Goods (2012 - 2016) Analysis & Trends
AbbVie (ABBV) has reported Finished Goods for 5 consecutive years, with $556.0 million the latest figure, recorded in Q2 2016.
- In Q2 2016, Finished Goods rose 16.32% year-over-year to $556.0 million; the TTM figure through Jun 2016 stood at $556.0 million (up 16.32% YoY), while the FY2015 annual figure was $469.0 million, up 37.54% from the prior year.
- Finished Goods improved to $556.0 million in Q2 2016 per ABBV's latest filing, from $552.0 million in the prior quarter.
- Across five years, Finished Goods topped out at $640.0 million in Q3 2015 and bottomed at $280.0 million in Q3 2014.
- Historically, Finished Goods has averaged $479.5 million across 5 years, with a median of $485.0 million in 2013.
- Annual changes were most pronounced in 2014 — Finished Goods plunged 41.42% — and 2015, when it jumped 128.57%.
- AbbVie's Finished Goods stood at $547.0 million in 2012, then declined by 11.33% to $485.0 million in 2013, then slipped by 29.69% to $341.0 million in 2014, then jumped by 37.54% to $469.0 million in 2015, then gained by 18.55% to $556.0 million in 2016.
- Business Quant data shows ABBV's Finished Goods at $556.0 million in Q2 2016, $552.0 million in Q1 2016, and $469.0 million in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 556.00 Mn |
| Mar 31, 2016 | 552.00 Mn |
| Dec 31, 2015 | 469.00 Mn |
| Sep 30, 2015 | 640.00 Mn |
| Jun 30, 2015 | 478.00 Mn |
| Mar 31, 2015 | 291.00 Mn |
| Dec 31, 2014 | 341.00 Mn |
| Sep 30, 2014 | 280.00 Mn |
| Dec 31, 2013 | 485.00 Mn |
| Sep 30, 2013 | 478.00 Mn |
| Jun 30, 2013 | 504.00 Mn |
| Mar 31, 2013 | 613.00 Mn |
| Dec 31, 2012 | 547.00 Mn |